<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        18-62-82
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1982
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GUTRON TAB 2.5 MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MIDODRINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        16.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="TAKEDA AUSTRIA GmbH" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            TAKEDA AUSTRIA GmbH
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Takeda Manufacturing Austria AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C01CA17
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gutron raises low blood pressure by improving the function of slackened blood vessels and thus preventing the pooling of large blood volumes in the legs which may cause dizziness and circulatory collapse because it leads to reduced blood perfusion of the brain.<br />Therapeutic indications<br />- Low blood pressure when standing up and upon prolonged standing (orthostatic hypotension).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Gutron 2.5 mg Tablets,<br />- if you are allergic to midodrine hydrochloride or any of the other ingredients of this medicine (listed in section 6)<br />- if you suffer from severe organic heart and blood vessel changes or disorders of heart rhythm<br />- if you have high blood pressure<br />- if you have any occlusive disorders of the blood vessels or disorders associated with vascular spasms<br />- if you have acute kidney disease<br />- if you have severe kidney dysfunction<br />- if you have an enlargement of the prostate gland with increased residual urine and mechanical urinary outflow obstructions<br />- if you have urinary retention<br />- if you have progressive nerve damage due to diabetes<br />- if you have a certain tumour of the medulla of the adrenal glands (called phaeochromocytoma)<br />- if you have an overactive thyroid gland (hyperthyroidism)<br />- if you have an eye disorder called glaucoma<br />- if you are pregnant or breast-feeding<br />Warnings and precautions<br />Talk to your doctor or pharmacist before taking Gutron.</p><p>Blood pressure in recumbent, sitting and standing position should be monitored at regular intervals during treatment. The potential for high blood pressure in recumbent or sitting position should be examined when starting treatment.<br />Your doctor may determine your liver and kidney function before starting treatment and monitor these functions at regular intervals.<br />If you notice any symptoms suggestive of high blood pressure (e.g. awareness of heartbeat, headache, visual disturbances) you must immediately stop treatment with Gutron and consult your doctor.<br />Your doctor may reduce your dosage to avoid side effects. Do not reduce your dose by yourself without having consulted your doctor.<br />Continued treatment with Gutron is only recommended, if initial treatment has been effective. In the case of major blood pressure fluctuations Gutron should be discontinued.<br />Please tell your doctor if you have an enlargement of the right heart ventricle (cor pulmonale) due to a disease of your lungs. In such a case your treatment will be monitored with particular caution.<br />Caution is required in patients with elevated intraocular pressure or with increased risk for raised intraocular pressure as well as in those with concurrent treatment with cortisone (because of the potential of an increase of intraocular pressure).<br />The use of the medicinal product Gutron 2.5 mg Tablets can lead to positive results in doping control tests.</p><p>Other medicines and Gutron 2.5 mg Tablets<br />Interactions may be experienced with medicines containing vasoconstrictive agents (e.g. reserpine, guanethidine, medicines against depression or allergies or thyroid hormones), other cardiovascular medicines (alpha-blockers, beta-blockers, digitalis) atropine-containing medicines as well as cortisone preparations (tablets, injections).<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br />IN PARTICULAR, TELL YOUR DOCTOR OR PHARMACIST IF YOU ARE TAKING ANY OF THE FOLLOWING:<br />&bull; Reserpine and guanethidine (medicines used to reduce high blood pressure), antihistamines (used to treat allergies), hormones for the thyroid (used when the thyroid is not working properly), tricyclic antidepressants and MAO-inhibitors (both used to treat depression) and other vasoconstrictors (medicines that narrow blood vessels), or sympathomimetic agents (medicines that have a stimulating effect on certain parts of the nervous system) because concomitant use with this medicine may cause a large increase in blood pressure.<br />&bull; Prazosin and phentolamine (medicines used to treat heart disease) because the effect of this medicine is blocked by these drugs.<br />&bull; Digitalis preparations (medicines used to treat heart disease) because concomitant use with this medicine may lead to cardiac dysfunction.<br />&bull; Fludrocortisone acetate (an anti-inflammatory medicine) because this medicine may increase its effect.<br />&bull; Medicines which directly or indirectly reduce your heart rate because if this medicine is combined with these medicines, it is advisable that your doctor closely monitors you.&rdquo;</p><p>Gutron 2.5 mg Tablets with food and drink<br />See section &ldquo;How to take Gutron 2.5 mg Tablets&ldquo;<br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.<br />As no clinical investigations are available, you should not take Gutron Tablets during pregnancy and breast-feeding. If you intend to become pregnant, you should not take Gutron Tablets. If you become pregnant while being treated, stop taking the medicine immediately and notify your doctor.<br />Driving and using machines<br />Caution; This medicine can affect your reaction and your ability to drive.<br />The effects of midodrine on reactivity and ability to drive have not been studied. When driving a vehicle or operating machines you should consider that unrest, excitability and irritability may develop.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.<br />The recommended dose is:<br />For low blood pressure:<br />Adults and adolescents (aged over 12 years):<br />The starting dose is 2.5 mg (1 tablet) two to three times daily.<br />Depending on your response and tolerability your doctor may increase this dose at intervals of at least 3-4 days to a maintenance dose of 10 mg (4 tablets) three times daily.<br />Maximum daily dose: 30 mg (12 tablets).<br />The interval between administrations should be 3-4 hours.<br />You should take Gutron at times when you are predominantly in upright position and follow your everyday routines.<br />Take your first dose shortly before or after getting up in the morning, the second dose at noon and the third dose in the late afternoon. Do not take Gutron after your evening meal or at a time of less than 4 hours before bedtime so as to reduce the risk of an increase of blood pressure when lying.<br />At the beginning of treatment you should regularly check your blood pressure in standing and recumbent position (at least two times per week). In case of an excessive increase of blood pressure when lying, stop taking Gutron and contact your doctor.<br />Use in children<br />Children under 12 years of age:<br />Because of the lack of experience use in children younger than 12 years is not recommended.<br />Elderly patients:<br />No data available.<br />Patients with impaired kidney function:<br />No specific studies regarding a potential dose reduction in patients with impaired kidney function have been conducted. Gutron is contraindicated, if you have acute kidney disease or severe kidney dysfunction.<br />Patients with impaired liver function:<br />No data available.<br />The duration of treatment will be decided by your doctor.<br />Method of administration<br />Take the tablets together with a glass of water.<br />The score line only serves for breaking the tablet, if you have problems swallowing the tablet whole.<br />If you take more Gutron 2.5 mg Tablets than you should<br />In the case of an overdose you may experience the symptoms described in the section &bdquo;Possible side effects&ldquo; with increased intensity, especially high blood pressure, goose pimples, sensation of coldness, slowed pulse and urinary retention.<br />You should contact your doctor immediately in such cases.<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />The following side effects are known:<br />Very common (may affect more than 1 of 10 patients treated)<br />Goose pimples, difficulties with emptying the bladder.<br />Common (may affect up to 1 of 10 patients treated)<br />High blood pressure when lying (up to 180/110 mmHg or higher &ndash; at doses of more than 30 mg per day), nausea and indigestion, heartburn, inflammation of the mucosa in the mouth, sensibility disorders (tingling, pins and needles), itching (predominantly on the scalp), chills, flushing, skin rash, urinary retention.<br />Uncommon (may affect up to 1 of 100 patients treated)<br />Problems sleeping, sleeplessness, headache, restlessness, excitability and irritability, slowed pulse rate, palpitation, high blood pressure when lying (180/110 mmHg or higher &ndash; at a dose of up to 7.5 mg per day), problems with passing water, urinary urgency.<br />Rare (may affect up to 1 of 1,000 patients treated)<br />Fast pulse rate, other disorders of heart rhythm, abnormal liver function tests, increase of liver enzymes<br />Not known (cannot be estimated from the available data)<br />Unrest, confusion, abdominal pain, vomiting, diarrhoea<br />Reporting of side effects<br />If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet.<br />Page 5 of 6<br />By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 25&deg;C. Store in the original package in order to protect from light.<br />Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the carton after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is: Midodrine hydrochloride. 1 tablet contains 2.5 mg midodrine hydrochloride<br />- The other ingredients are: magnesium stearate, talc, colloidal anhydrous silica, microcrystalline cellulose, maize starch.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                White, round tablets embossed with “GU” above and “2.5” below the score line.
Available in a pack of 20 or 50 tablets.
Not all pack sizes may be marketed in all countries.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder:<br />Takeda Austria GmbH, St.-Peter-Stra&szlig;e 25, 4020 Linz, Austria<br />Manufacturer:<br />Takeda GmbH, Manufacturing Site Oranienburg, 16515 Oranienburg, Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in February 2016.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>یرفع غوترون ضغط الدم المنخفض عن طریق تحسین أداء الأوعیة الدمویة المتباطئة وبالتالي یمنع احتشاد كمیات كبیرة من الدم في<br />الساقین والتي قد تؤدي للدوار وانھیار الدورة الدمویة لأنھا تتسبب في تقلیل ترویة المخ بالدم.</p><p>دواعي الاستعمال<br />- ضغط الدم المنخفض عند الوقوف وعند الوقوف لمدة طویلة (ھبوط ضغط الدم الانتصابي).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تتناول أقراص غوترون ۲٫٥ ملجم في الحالات التالیة:<br />.( - إن كانت لدیك حساسیة من مادة میدودرین ھیدروكلورید أو أیة مكونات أخرى لھذا الدواء (مدرجة بالفقرة ٦<br />- إن كنت تعاني من تغیرات عضویة حادة بالقلب والأوعیة الدمویة أو اضطرابات إیقاع نبض القلب.<br />- إن كنت تعاني من ضغط الدم المرتفع.<br />- إن كنت تعاني من أي من اضطرابات الأوعیة الدمویة الانسدادیة أو اضطرابات متعلقة بانقباض الأوعیة الدمویة.<br />- إن كنت تعاني من مرض كلوي حاد.<br />- إن كنت تعاني من اختلال حاد بوظائف الكلى.<br />- إن كنت مصابا بتضخم غدة البروستاتا مع زیادة في كمیة البول المتخلف وانسداد میكانیكي في تدفق البول.<br />- إن كنت مصابا باحتباس البول.<br />- إن كنت مصابا بتضرر متقدم في الأعصاب بسبب داء السكري.<br />- إن كنت مصابا بورم معین في لب الغدد الكظریة (یسمى ورم القواتم).<br />- إن كنت مصابا بفرط نشاط الغدة الدرقیة.<br />- إن كنت مصاباً باضطرابات العین المسماة الزرق (المیاه الزرقاء).<br />- في حالة الحمل أو الرضاعة.<br />التحذیرات والاحتیاطات:<br />استشر طبیبك أو الصیدلي قبل تناول جوترون.<br />یجب أن تتم مراقبة ضغط الدم في أوضاع الاستلقاء والجلوس والوقوف على فواصل زمنیة منتظمة خلال فترة العلاج. یجب أن یتم<br />اختبار احتمالیة ارتفاع ضغط الدم في وضع الاستلقاء أو الجلوس عند بدء العلاج.<br />قد یقوم طبیبك بتقییم وظائف الكبد والكلى قبل بدء العلاج ومراقبة ھذه الوظائف على فواصل زمنیة منتظمة.<br />إذا لاحظت أیة أعراض توحي بارتفاع ضغط الدم (مثل الإحساس بضربات القلب والصداع والاضطرابات البصریة)، فیجب علیك إیقاف<br />العلاج بغوترونواستشارة الطبیب فورا.ً<br />قد یقلل طبیبك من جرعتك لتفادي الأعراض الجانبیة. لا تقلل جرعتك من تلقاء نفسك بدون استشارة طبیبك.<br />یوصى بالعلاج المستمر بغوترونفقط في حالة أن العلاج الأولي كان فعالا . في حالة حدوث تقلبات كبیرة بضغط الدم، فلابد من إیقاف<br />تناول جوترون.<br />یرجى إبلاغ طبیبك إن كنت مصابا بتضخم في بطین القلب الأیمن بسبب مرض برئتیك. في ھذه الحالة ستتم مراقبة علاجك بمحاذیر<br />خاصة.<br />الحذر مطلوب في المرضى المصابین بارتفاع ضغط العین أو ارتفاع احتمالیة التعرض لارتفاع ضغط العین كما في تلك الحالات التي<br />تتلقى علاجا متزامنا بالكورتیزون (بسبب احتمالیة زیادة ضغط العین).<br />یمكن أن یؤدي استخدام المنتج الطبي أقراص غوترون ۲٫٥ ملجم إلى نتائج إیجابیة في فحص الكشف عن المواد المخدرة.<br />العقاقیر الأخرى وغوترون ۲٫٥ ملجم أقراص:<br />قد تحدث تفاعلات مع العقاقیر المحتویة على عناصر قابضة للأوعیة الدمویة (مثل: ریسبرین وجوانیثیدین والعقاقیر المضادة للاكتئاب أو<br />الحساسیة أو ھرمونات الغدة الدرقیة)، وعقاقیر القلب والأوعیة الدمویة الأخرى (مثل حاصرات ألفا وحاصرات بیتا والدیجیتالیس)<br />والعقاقیر المحتویة على الأتروبین بالإضافة لمستحضرات الكورتیزون (أقراص وحقن).<br />أبلغ طبیبك أو الصیدلي إذا كنت تتناول أو تناولت مؤخرا أو قد تتناول أیة أدویة أخرى.<br />أبلغ طبیبك أو الصیدلي إذا كنت تتناول أیا من الأدویة التالیة بشكل خاص:<br />&bull; الریسبرین والجوانیثیدین (أدویة تُستخدم لتخفیض ارتفاع ضغط الدم)، ومضادات الھیستامین (المستخدمة لعلاج الحساسیة)،<br />وھرمونات الغدة الدرقیة (التي تُستخدم عندما تفشل الغدة الدرقیة في أداء وظیفتھا بشكل سلیم)، ومضادات الاكتئاب ثلاثیة<br />ویُستخدم كلاھما لعلاج الاكتئاب) ، وقابضات الأوعیة الدمویة ) (MAOI) الحلقات ومثبطات الإنزیم المؤكسد أحادي الأمین<br />الأخرى (وھي أدویة تضیق من الأوعیة الدمویة)، أو العناصر المحاكیة للتأثیر السمبتاوي (وھي أدویة لھا تأثیر محفز على<br />أجزاء معینة من الجھاز العصبي) لأن الاستخدام المتزامن مع ھذه الأدویة قد یسبب ارتفاع اً كبیر اً في ضغط الدم.<br />&bull; برازوسین وفینتولامین (أدویة تُستخدم لعلاج أمراض القلب) لأن ھذه الأدویة تمنع تأثیر ھذا الدواء.<br />&bull; مستحضرات الدیجیتالیس (وھي أدویة تُستخدم لعلاج أمراض القلب) لأن الاستخدام المتزامن مع ھذا الدواء قد یؤدي إلى<br />قصور في القلب.<br />&bull; أسیتات الفلودروكورتیزون (دواء مضاد للالتھاب) لأن ھذا الدواء قد یزید من تأثیره.<br />&bull; الأدویة التي تخفض بشكل مباشر أو غیر مباشر على معدل ضربات قلبك، لأنھ إذا تم تناول ھذا الدواء بالتزامن مع ھذه<br />الأدویة، فیفضل أن یتولى طبیبك مراقبتك عن قرب .<br />غوترون ۲٫٥ ملجم أقراص مع الطعام والشراب<br />أنظر الفقرة &quot;كیف تتناول غوترون ۲٫٥ ملجم أقراص&quot;.<br />الحمل والرضاعة<br />یجب استشارة الطبیب قبل تناول ھذا الدواء في حالة الحمل أو الرضاعة أو الاشتباه في الحمل أو انتظار مولود .<br />یجب علیكِ عدم تناول أقراص غوترونخلال الحمل والرضاعة نظراً لعدم توافر الأبحاث السریریة. وإن كنتِ تنوین الحمل، فیجب ألا<br />تتناولین أقراص جوترون. في حالة حدوث الحمل أثناء العلاج، یجب التوقف عن تناول الدواء فورا وإبلاغ طبیبك.<br />القیادة واستعمال الماكینات:<br />تحذیر: یمكن لھذا العقار أن یؤثر على ردود فعلك وقدرتك على القیادة.<br />لم تتم دراسة تأثیر المیدودرین على التفاعلیة والقدرة على القیادة. عندما تقود سیارة أو تدیر ماكینة، فتوقع حدوث اضطراب واستثارة<br />وتھیج.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول ھذا العقار دوما كما وصف لك الطبیب. تحقق من طبیبك إن لم تكن متأكداً.<br />الجرعة الموصى بھا ھي:<br />لضغط الدم المنخفض:<br />البالغون والمراھقون (أكبر من ۱۲ عاما):<br />جرعة البدایة ھي ۲٫٥ ملجم ( ۱ قرص) مرتان إلى ثلاثة یومیا.ً<br />٤ أیام على الأقل إلى جرعة مداومة بمقدار ۱۰ ملجم ( ٤ - اعتماداً على استجابتك وتحملك فقد یزید الطبیب ھذه الجرعة على فترات من ۳<br />أقراص) ۳ مرات یومیا.ً<br />الجرعة الیومیة القصوى: ۳۰ ملجم ( ۱۲ قرص اً).<br />٤ ساعات. - الفاصل الزمني بین تناول الجرعات یجب أن یكون ۳<br />یجب أن تتناول غوترونفي الأوقات التي تكون فیھا في وضع قائم أغلب الوقت وتابع نظام حیاتك الیومي.<br />تناول جرعتك الأولى قبل أو بعد الاستیقاظ في الصباح بفترة قصیرة، الجرعة الثانیة عند الظھیرة والجرعة الثالثة في وقت متأخر من<br />بعد الظھیرة. لا تتناول غوترونبعد وجبتك المسائیة أو قبل النوم بأقل من أربع ساعات حتى تقلل من مخاطر ارتفاع ضغط الدم أثناء<br />النوم.<br />عند بدایة العلاج یجب أن تفحص ضغط دمك بانتظام في وضع الوقوف والاستلقاء (على الأقل مرتان بالأسبوع). في حالة ارتفاع ضغط<br />الدم الحاد عند الاستلقاء، توقف عن تناول غوترونواستشر طبیبك.<br />علاج إضافي لتسریب البول اللاإرادي:<br />البالغون:<br />۲٫٥ ملجم ( ۱ قرص) مرتان إلى ثلاثة یومیا وحتى ٥ ملجم (قرصان) مرتان یومیا.ً<br />الجرعة الیومیة القصوى: ۱۰ ملجم ( ٤ أقراص)<br />لتقلیل احتمالیة ارتفاع ضغط الدم أثناء النوم، یجب عدم تناول غوترونبعد الوجبة المسائیة أو قبل النوم بأربع ساعات على الأقل.<br />الاستخدام في الأطفال<br />الأطفال أقل من ۱۲ عام:<br />لا یوصى باستخدامھ نظراً لقلة الخبرة بالاستخدام في الأطفال الأصغر من ۱۲ عام.<br />المرضى الأكبر سناً:<br />لا توجد بیانات متاحة.<br />المرضى المصابون باعتلال وظائف الكلى:<br />لم یتم إجراء دراسات محددة بخصوص تخفیض الجرعة المحتمل في المرضى المصابین باعتلال وظائف الكلى. یُمنع استخدام غوترونإن<br />كنت مصابا بمرض كلوي حاد أو اختلال حاد في وظائف الكلى.<br />المرضى المصابون باعتلال وظائف الكبد:<br />لا توجد بیانات متاحة.<br />سیقوم الطبیب بتحدید مدة العلاج.<br />وسیلة تناول الدواء:<br />تناول الأقراص مع كوب من الماء.<br />خط التفریق لا یستخدم إلا لكسر القرص، إن كان یصعب علیك ابتلاع القرص كاملاً.<br />إذا تناولت جرعة زائدة من أقراص غوترون ۲٫٥ ملجم :<br />في حالة تناول جرعة زائدة قد تنتابك بعض الأعراض الموصوفة بفقرة &quot;الأعراض الجانبیة المحتملة&quot; بحدة متزایدة، خاصةً ارتفاع<br />ضغط الدم والبثرات الشبیھة بجلد الأوزة والشعور بالبرد وتباطؤ النبض واحتباس البول.<br />یجب علیك استشارة طبیبك فوراً في مثل تلك الحالات.<br />إذا كان لدیك مزیداً من الأسئلة حول استخدام ھذا العقار، سل طبیبك أو الصیدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل كافة العقاقیر، فإن ھذا العقار یمكن أن یسبب أعراض اً جانبیة، على الرغم من أنھا لا تصیب الجمیع.<br />الأعراض الجانبیة التالیة معروفة:<br />شائعة جدا (قد تصیب أكثر من ۱ من كل ۱۰ مرضى تلقوا العلاج)<br />البثرات الشبیھة بجلد الأوزة وصعوبات بإفراغ المثانة.<br />شائعة (قد تصیب حتى ۱ من كل ۱۰ مرضى تلقوا العلاج)<br />۱۱۰ ملم زئبق أو أكثر &ndash; بجرعات أكثر من ۳۰ ملجم في الیوم) والغثیان وعسر الھضم / ارتفاع ضغط الدم عند الاستلقاء (حتى ۱۸۰<br />وحرقة المعدة والتھاب الأغشیة المخاطیة بالفم والاضطرابات الحسیة (الخدر والتنمیل) والحكة (في الغالب على فروة الرأس)<br />والقشعریرة والاحمرار وطفح الجلد واحتباس البول.<br />غیر شائعة (قد تصیب حتى ۱ من كل ۱۰۰ مریض تلقوا العلاج)<br />۱۱۰/ مشاكل بالنوم والأرق والصداع والتوتر والاستثارة والتھیج وتباطؤ معدل النبض والخفقان وارتفاع ضغط الدم عند الاستلقاء ( ۱۸۰<br />ملم زئبق أو أعلى &ndash; بجرعة تصل إلى ۷٫٥ ملجم في الیوم) ومشاكل في التخلص من الماء والإلحاح البولي.<br />نادرة (قد تصیب حتى ۱ من كل ۱۰۰۰ مریض تلقوا العلاج)<br />تسارع معدل النبض واضطرابات أخرى لإیقاع القلب ونتائج غیر طبیعیة لفحوص وظائف الكبد وارتفاع إنزیمات الكبد.<br />غیر معروفة (لا یمكن تقدیرھا بالبیانات المتاحة)<br />التوتر والارتباك وألم البطن والقيء والإسھال.<br />الإبلاغ عن الأعراض الجانبیة<br />إذا تعرضت لأیة أعراض جانبیة، تحدث مع طبیبك. یشمل ذلك الأعراض الجانبیة المحتملة غیر المدرجة بھذه النشرة.<br />بالإبلاغ عن الأعراض الجانبیة ستساعد في تقدیم معلومات أكثر عن أمان ھذه الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>یخزن في درجة حرارة أقل من ۲٥ &deg;مئویة. یخزن في العبوة الأصلیة من أجل الحمایة من الضوء.<br />احتفظ بھذا العقار بعیداً عن نظر ومتناول ید الأطفال.<br />EXP&quot; لا تستخدم ھذا العقار بعد انتھاء تاریخ الصلاحیة المذكور على العلبة الكارتونیة بعد كلمة &quot;. یشیر تاریخ انتھاء الصلاحیة إلى الیوم<br />الأخیر من ذلك الشھر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ماذا تحتوي أقراص غوترون ۲٫٥ ملجم<br />- المادة الفعالة ھي: میدودرین ھیدروكلورید. القرص الواحد یحتوي على ۲٫٥ ملجم میدودرین ھیدروكلورید.<br />- المكونات الأخرى ھي: سترات الماغنسیوم ومسحوق التلك والسلیكا الغرویة اللامائیة والمایكروكریستالین سلیلوز ونشا الذرة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص بيضاء ومستديرة محفور عليها &ldquo;GU&rdquo;أعلى خط التفريق و&quot; 2.5&quot; أسفله.<br />متوفر في عبوة تحتوى على ۲۰ قرص أو ٥۰ قرص.<br />قد لا یتم تسویق كل أحجام العلب في جمیع البلدان.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>Takeda Austria GmbH<br />St.-Peter-Stra&szlig;e 25<br />4020 Linz, Austria<br />الشركة المصنعة:<br />Takeda GmbH<br />Production site Oranienburg<br />Lehnitzstra&szlig;e 70 - 98<br />16515 Oranienburg, Germany</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة ھذه النشرة آخر مرة بتاریخ فبرایر ۲۰۱
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                GUTRON 2.5 mg - Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 2.5 mg midodrine hydrochloride
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet
White, round tablet embossed with “GU“ above and with “2.5“ below the score line.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Orthostatic hypotension</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology:<br />Orthostatic hypotension<br />Treatment should be conducted with adequate consideration of the patient&rsquo;s tonus and the responsiveness of the patient&rsquo;s autonomous nervous system and should be adjusted to individual requirements.<br />The following dosing guidelines are applicable:<br />Adults and juveniles (&gt; 12 years):<br />Initial dose 2.5 mg 2-3 times daily.<br />This dosage may be increased depending on the patient&rsquo;s response and tolerability at intervals of at least 3 to 4 days up to a maintenance dose of 10 mg three times daily.<br />Maximum daily dose: 30 mg.<br />Midodrine should be taken during daytime with the patient in upright position and pursuing his/her normal everyday activities.<br />The recommended dosing interval is 3-4 hours.<br />The first dose should be taken shortly before or after getting up in the morning, the second dose at noon and the third dose in the late afternoon.<br />For minimizing the risk of supine hypertension midodrine should not be taken after the evening meal or less than 4 hours before bedtime.<br />Special patient populations<br />Children younger than 12 years:<br />Considering the lack of experience use in children younger than 12 years is not recommended.<br />Elderly patients:<br />No specific studies regarding a potential dose reduction in elderly patients have been conducted.<br />Patients with impaired renal function:<br />No specific studies regarding a potential dose reduction in elderly patients have been conducted. Generally, midodrine is contraindicated in patients with acute renal disease or severe impairment of renal function (see section 4.3).<br />Patients with impaired hepatic or renal function:<br />No data available.<br />Method of administration:<br />For oral use<br />GUTRON 2.5 mg &ndash; Tablets are taken together with some fluid (e.g. a glass of water).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
• Severe organic heart or vascular disease, arrhythmias.
• Hypertension
• Severe obliterative vascular disease or disorders associated with vascular spasms
• Acute renal disease
• Severe renal impairment
• Prostatic hyperplasia with increased residual urine volume
• Mechanical urinary outflow obstruction
• Urinary retention
• Proliferative diabetic neuropathy
• Phaeochromocytoma
• Hyperthyroidism
• Narrow angle glaucoma
• Pregnancy and lactation
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>During treatment supine, sitting and standing blood pressure is to be monitored at regular intervals.<br />The potential for supine or sitting hypertension should be evaluated when initiating treatment.<br />The patients should be advised of the symptoms suggestive of hypertension (cardiac awareness, headache, visual disturbances) and should be cautioned to discontinue treatment and notify their doctor immediately in any such cases.<br />Development of supine hypertension may often be avoided by an appropriate dose reduction.<br />Continual use is only recommended in patients having shown adequate response to initial treatment. Midodrine should be discontinued in the case of major fluctuations of blood pressure.<br />Concomitant use of sympathomimetics and other vasopressor agents such as reserpine, guanethidine, tricyclic antidepressants, antihistamines, thyroid hormones and MAO inhibitors should be avoided as a marked blood pressure increase may be experienced.<br />Bradycardia being essentially reflectory in nature may occur during treatment; therefore, caution is indicated with the concomitant use of medications directly or indirectly slowing the heart rate (e.g. digitalis, beta-blockers, psychopharmaceutical agents).<br />The patients are to be made aware of symptoms suggestive of bradycardia (e.g. slowed pulse, cardiac awareness, increased dizziness, loss of consciousness) and advised to discontinue treatment and notify their doctor immediately in such cases.<br />Patients with cor pulmonale require particularly careful supervision.<br />Caution is indicated in patients with glaucoma/increased intraocular pressure or increased risk for such conditions as well as in those with concomitant treatment with mineralocorticoids/fludrocortisone (because of the potential increase of intraocular pressure).<br />No data is available for the use in patients with impaired hepatic and renal function. Therefore, parameters of hepatic and renal function should be evaluated before starting treatment and monitored at regular intervals.<br />No data is available on the use in children below 12 years of age and in elderly patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Midodrine is an inhibitor of cytochrome P450 CYP2D6 and may therefore affect the metabolism of other drugs metabolised by this isoenzyme. This may lead to increased systemic exposure and increased effects of these drugs.<br />Concomitant use of sympathomimetics and other vasopressor agents such as reserpine, guanethidine, tricyclic antidpressants, antihistamines, thyroid hormones and MAO inhibitors should be avoided as marked increase of blood pressure may be experienced.<br />The effects of midodrine may be antagonised by alpha-adrenoceptor blockers (such as prazosine, phentolamine). Concomitant use of beta-adrenoceptor blockers may produce increased bradycardia. Close monitoring will be required.<br />Concomitant use of digitalis is not recommended, as the bradycardia occurring with the use of midodrine will be potentiated and may produce heart block.<br />Concomitant use of atropine and corticosteroids may cause enhanced or excessive blood pressure increase.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Pregnancy Category C. Midodrine has been shown to have an embryocidal effect in rats and rabbits when given in doses (50) times the human dose. There are no adequate and well-controlled studies in pregnant women. Midodrine is contraindicated in women who are or may<br />become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus.<br />Breastfeeding<br />It is unknown whether midodrine or desglymidodrine is excreted in breast milk.<br />Therefore, midodrine must not be used while breastfeeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no studies on the effect of midodrine on reactivity and ability to drive. When driving a vehicle it should be considered that restlessness, excitability and irritability may be experienced occasionally.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Evaluation of adverse effects has been based on the following frequency categories:<br />Very common (&ge;1/10); common (&ge;1/100, &lt;1/10); uncommon (&ge;1/1,000, &lt;1/100); rare (&ge;1/10,000, &lt;1/1,000); very rare (&lt;1/10,000); not known (cannot be estimated from the available data).<br />Psychiatric disorders<br />Uncommon: Sleep disorders, insomnia<br />Not known: Restlessness, confusion<br />Nervous system disorders<br />Common: Paraesthesia<br />Uncommon: Headache, restlessness, excitability and irritability<br />Cardiac disorders<br />Uncommon: Reflex bradycardia, palpitations<br />Rare: Tachycardia, ventricular arrhythmias<br />Vascular disorders<br />Common: Supine hypertension (blood pressure &ge; 180/110 mmHg) at a dosage of more than 30 mg daily<br />Uncommon: Supine hypertension (blood pressure &ge; 180/110 mmHg) at a dosage of up to 7.5 mg daily<br />Gastrointestinal disorders<br />Common: Nausea/dyspepsia, heartburn, stomatitis<br />Not known. Abdominal pain, vomiting, diarrhoea<br />Hepatobiliary disorders<br />Rare: Abnormal hepatic function tests, increase of hepatic enzymes<br />Skin and subcutaneous tissue disorders<br />Very common: Piloerection (goose pimples) (13%)<br />Common: Pruritus (mainly in head region), chills, flushing, skin rash<br />Renal and urinary disorders<br />Very common: Dysuria (13%)<br />Common: Urinary retention (6%)<br />Uncommon: Micturition disorders, urinary urgency<br />Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222<br />Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />In the case of overdose the symptoms listed as adverse effects may occur in potentiated form, in particular hypertension, piloerection, chills, bradycardia and urinary retention.<br />Treatment of overdose<br />In addition to general measures of detoxification, induced vomiting and the use of alpha-sympatholytics (e.g. phentolamine, nitroglycerine) may be required.<br />Bradycardia and bradycardic arrhythmias may be treated with atropine (caution: blood pressure increase).<br />The active metabolite desglymidodrine is dialysable.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Cardiac stimulants, excl. cardiac glycosides; adrenergic and dopaminergic agents, ATC-Code: C01CA17<br />Midodrine is a prodrug and is converted to the active substance desglymidodrine by enzymatic hydrolysis. Desglymidodrine selectively stimulates peripheral &alpha;1-adrenoceptors. It shows no activity on myocardial &beta;-adrenoceptors.<br />This action is essentially consistent with that of other alpha-sympathomimetics.<br />This action is associated with an increase of systolic and diastolic blood pressure and with reflectory bradycardia.<br />The increase of blood pressure is primarily based on a constriction of smaller veins and &ndash; to a lesser extent &ndash; of the arterioles (increase of peripheral resistance).<br />Desglymidodrine causes a minor reduction of cardiac output and of renal blood flow.<br />The urinary bladder shows an increase of tone of the internal sphincter and thus a delay in voiding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Following oral dosing in healthy subjects midodrine is rapidly and almost completely absorbed.<br />In healthy subjects and patients with orthostatic hypotension, peak plasma levels of desglymidodrine are achieved after approximately 1 hour.<br />Absolute bioavailability (as desglymidodrine) after oral dosing is 93%.<br />Distribution<br />The distribution of midodrine has not been studied. Midodrine does not appear to cross the blood-brain barrier.<br />Following a dose of 2.5 mg peak plasma levels of 10 &mu;g/l will be achieved within 30 minutes.<br />Biotransformation<br />Midodrine is converted to the active metabolite desglymidodrine by enzymatic hydrolysis in various tissues (including the liver).<br />Elimination<br />The plasma elimination half-life (t1/2&beta;) of midodrine is 0.49 hours, that of the active metabolite 2-4 hours.<br />Midodrine and its metabolites are almost completely eliminated with the urine within 24 hours with about 40-60% eliminated as active primary metabolite, about 2-5% as unchanged midodrine and the rest as pharmacologically inactive metabolites.<br />Midodrine does not appear to cross the blood-brain barrier.<br />No kinetic data for elderly patients or those with impaired hepatic or renal function are available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In addition to the pharmacological effects of midodrine, studies of repeated dose toxicity showed marked degenerative renal changes in rats and hepatic changes in rats and dogs at doses being the 12- to 50-fold (in mg/kg) of the maximum therapeutic dose in humans.<br />In preclinical studies, midodrine has been shown to be non-teratogenic and non-mutagenic.<br />In carcinogenicity studies in rats increased tumour incidence in testicular interstitial cells was seen; the relevance of this finding for humans is unknown.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Magnesium stearate<br />Talc<br />Colloidal anhydrous silica<br />Microcrystalline cellulose<br />Maize starch</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C.<br />Store in the original package in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>20 or 50 tablets in PVC/PVdC/Al blister packs</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Takeda Austria GmbH, St.-Peter-Straße 25, 4020 Linz
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2014
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>